Objective To analyze the advantages of using ultra early minimally invasive small bone window debridement in the treatment of patients with cerebral hemorrhage. Methods: 88 patients in this study were all patients with intracerebral hemorrhage who received surgical treatment in our hospital from December 2020 to November 2022. They were divided into control group and observation group according to the different operation time. During this period, 44 patients in the control group were treated with minimally invasive small bone window removal in the early stage (within 6-24h of onset), and 44 patients in the observation group were treated with minimally invasive small bone window removal in the ultra early stage (within 6h of onset). The treatment conditions of the two groups were reviewed and judged, and based on this, the therapeutic effect related indicators were compared and analyzed. Results: There was no significant difference in Ang-1 and inflammatory factor related indexes between the two groups before treatment (P＞0.05); Although the levels of the above indicators decreased after treatment, the levels of various indicators in the observation group were significantly lower than those in the control group (P＜0.05). The total effective rate of 95.45％ in the observation group was significantly higher than that of 75.00％ in the control group (P＜0.05). Conclusion: During the treatment of patients with cerebral hemorrhage, the use of ultra early minimally invasive bone window removal is more conducive to improving the treatment effect and promoting the recovery speed of patients, which is worthy of active application in clinical practice.
关键词
超早期小骨窗微创清除术/脑出血/临床效果/血管生成素1
Key words
Minimally invasive removal of small bone window at super early stage/Cerebral hemorrhage/Clinical effect/Angiopoietin 1
万方数据